Results 311 to 320 of about 5,871,156 (346)

Chronic Pancreatitis and Pancreatic Cancer

Digestive Diseases, 2002
Pancreatic cancer is the fourth leading cause of cancer deaths in the USA in both sexes. Early diagnosis is difficult and the overall mortality rate is high. Individuals at high risk for pancreatic cancer include smokers, and persons with all forms of chronic alcoholic, metabolic, tropical or hereditary pancreatitis.
Patrick, Maisonneuve, Albert B, Lowenfels   +1 more
openaire   +2 more sources

Familial Pancreatic Cancer

Oncology Research and Treatment, 2018
Familial pancreatic cancer accounts for 10% of all patients with pancreatic cancer. Because the 5-year survival rate of pancreatic cancer is only 7%, screening programs for high-risk individuals are essential and might be advantageous. Pancreatic ductal adenocarcinoma mostly shows symptoms at an advanced state and treatment is not efficient enough to ...
Julia, Benzel, Volker, Fendrich
openaire   +2 more sources

Pancreatic cancer screening

Abdominal Radiology, 2017
This article reviews the current evidence surrounding pancreatic cancer screening. The current targets of screening include identification of early pancreatic cancer, as well as the two most important precursor lesions; intraductal papillary mucinous neoplasm and high grade pancreatic intraepithelial neoplasia.
Chris M, Lindquist, Frank H, Miller, Nancy A, Hammond, Paul, Nikolaidis   +3 more
openaire   +2 more sources

Neoadjuvant therapy for pancreatic cancer

Nature Reviews Clinical Oncology, 2023
C. Springfeld, C. Ferrone, M. Katz, P. Philip, T. Hong, T. Hackert, M. Büchler, J. Neoptolemos   +7 more
semanticscholar   +1 more source

Pancreatic cancer chemoradiotherapy

Best Practice & Research Clinical Gastroenterology, 2016
Pancreatic cancer is the most lethal gastrointestinal tumour. Chemotherapy is the mainstay of therapy in the majority of the patients whereas resection is the only chance of cure but only possible in 15-20% of all patients. The integration of radiotherapy into multimodal treatment concepts is heavily investigated.
Brunner, Thomas, Seufferlein, Thomas
openaire   +3 more sources

Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer

Nature reviews: Gastroenterology & hepatology, 2023
T. Stoop, R. Theijse, L. Seelen, B. Groot Koerkamp, C. V. Eijck, C. Wolfgang, G. Tienhoven, H. C. Santvoort, I. Molenaar, J. Wilmink, M. Del Chiaro, Matthew H. G. Katz, T. Hackert, M. Besselink, International Collaborative Group on Locally Advanced Pancreatic Cancer   +14 more
semanticscholar   +1 more source

Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis.

Cancer Letters, 2021
J. Cai, Hongda Chen, M. Lu, Yuhan Zhang, B. Lu, L. You, Taiping Zhang, M. Dai, Yupei Zhao   +8 more
semanticscholar   +1 more source

Pancreatic Resection for Pancreatic Cancer

Surgical Clinics of North America, 1989
In the majority of patients, pancreatic resection is performed for a proved carcinoma or for a mass in the pancreas with clinical features of carcinoma. Preoperative preparation is similar to that for other cancer operations, and good nutritional status and normal clotting factors are important.
openaire   +2 more sources

Obesity, Pancreatitis, and Pancreatic Cancer

Obesity Surgery, 2008
The only universally accepted risk factors for the development of pancreatic cancer are a positive family history or a history of smoking. Although the contribution of pancreatitis to pancreatic carcinogenesis has been debated for decades in the epidemiology literature, the actual mechanism is still unclear.
openaire   +2 more sources

Pancreatic Cancer

Surgical Oncology Clinics of North America, 2021
openaire   +2 more sources